Primary effusion lymphoma (Q39101): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Linfoma não Hodgkin agressivo de células B composto de células grandes, apresentando-se como um derrame seroso sem massas tumorais detectáveis. Está universalmente associado ao vírus do herpes humano 8 (HHV-8)/vírus do herpes do sarcoma de Kaposi (KSHV) [HHV-8/KSHV]. Ocorre principalmente no contexto de imunodeficiência; a maioria dos casos foi relatada em pacientes HIV positivos. As localizações de envolvimento mais comuns são as cavidades pleural, pericárdica e peritoneal. O prognóstico é extremamente desfavorável. | |||
| description / en | description / en | ||
An aggressive non-Hodgkin B-cell lymphoma composed of large cells, presenting as a serous effusion without detectable tumour masses. It is universally associated with human herpes virus 8 (HHV-8)/Kaposi sarcoma herpes virus (KSHV) [HHV-8/KSHV]. It mostly occurs in the setting of immunodeficiency; most cases have been reported in HIV positive patients. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. The prognosis is extremely unfavorable. | |||
Revision as of 04:25, 13 August 2026
An aggressive non-Hodgkin B-cell lymphoma composed of large cells, presenting as a serous effusion without detectable tumour masses. It is universally associated with human herpes virus 8 (HHV-8)/Kaposi sarcoma herpes virus (KSHV) [HHV-8/KSHV]. It mostly occurs in the setting of immunodeficiency; most cases have been reported in HIV positive patients. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. The prognosis is extremely unfavorable.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A81.9 |
||
| English | Primary effusion lymphoma |
An aggressive non-Hodgkin B-cell lymphoma composed of large cells, presenting as a serous effusion without detectable tumour masses. It is universally associated with human herpes virus 8 (HHV-8)/Kaposi sarcoma herpes virus (KSHV) [HHV-8/KSHV]. It mostly occurs in the setting of immunodeficiency; most cases have been reported in HIV positive patients. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. The prognosis is extremely unfavorable. |
